Investigating the Inhibitory Effects of Curcumin and its Derivatives on Protease Activity for HIV Treatment Development

This investigation explores the extent to which natural compounds in Curcuma longa, including derivatives and analogs, inhibit HIV Protease activity and their potential to reduce long-term NHS treatment costs.

Employing a literature-based approach, the study analyzes secondary quantitative data, including IC50, Km, Vmax, and binding free energy (ΔG), alongside computational molecular docking simulations.

Findings indicate that while natural curcumin exhibits weak binding affinity for HIV-1 PR, synthetic analogs show significantly stronger inhibitory potential. However, the complexity of synthesizing these derivatives may offset economic benefits.

The essay excels in its critical evaluation of computational docking reliability and the comparative analysis of enzyme-specific catalytic residues and protease types.